ResMed investors sleep soundly | Figma pops 250% on IPO | Ozempic faces a new challenger

Sun Aug 03 2025

Get AI-powered summaries and transcripts for any meeting, phone call, or podcast.

AI SummariesFull TranscriptsSpeaker Identification

Available on iOS, Android, Mac, and Windows

No transcript available.